AcaHealth Pharma & Biotech Co.,LTD

長安醫藥生技 Innovative R&D

Chronic obstructive pulmonary diseases

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that cause breathing difficulties.
 
 
COPD is a common condition that mainly affects middle-aged or older adults who smoke.
The breathing problems tend to get gradually worse over time and can limit your normal activities, although treatment can help keep the condition under control.
 
 
Treatments for COPD
The damage to the lungs caused by COPD is permanent.
There's currently no cure for chronic obstructive pulmonary disease (COPD), but treatment can help slow the progression of the condition and control the symptoms.
 
 
Advantage of AH-701-COPD :
1.
AH-701-COPD is an EPO inducer for activating mitochondrial biogenesis and hemoglobin production.
2.
AH-701-COPD can improve bleomycin-induced COPD mice model as regenerative drug for lung fibrosis.
Copyright © 2020 長安醫藥生技 AcaHealth Pharma & Biotech Company

WebMake SiteBuild | HiYP B2B Service | TaiwanDNS